Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
25.49
-0.11 (-0.43%)
Mar 18, 2026, 10:43 AM EDT - Market open
Surrozen Market Cap
Surrozen has a market cap or net worth of $218.49 million as of March 18, 2026. Its market cap has increased by 528.32% in one year.
Market Cap
218.49M
Enterprise Value
145.18M
1-Year Change
528.32%
Ranking
Category
Stock Price
$25.49
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $218.49M, an increase of 81.09%. That is a compound annual growth rate of 12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 238.66M | 13.27% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 227.59M |
| Elicio Therapeutics | 224.43M |
| Achieve Life Sciences | 221.99M |
| Keros Therapeutics | 217.29M |
| Humacyte | 217.23M |
| MediWound | 212.81M |
| Compugen | 211.80M |
| SAB Biotherapeutics | 211.45M |